Concepedia

Publication | Open Access

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

DOIFull Paper Access

381

Citations

12

References

1992

Year

Thomas C. Merigan, Dale G. Renlund, Susan Keay, Michael R. Bristow, Vaughn A. Starnes, John B. O’Connell, Silvia Resta, Diane Dunn, P. Gamberg, Ranae M. Ratkovec,
New England Journal of Medicine

Abstract

The prophylactic administration of ganciclovir after heart transplantation is safe, and in CMV-seropositive patients it reduces the incidence of CMV-induced illness.

References

YearCitations

Page 1